Monsanto Roundup Lawsuit

Wednesday, July 23, 2008

Dan Troy appointed as Senior Vice President and General Counsel for GlaxoSmithKline

Is this a case of you scratch our back... and we will scratch yours?


Source: GSK Website

Dan Troy has been appointed as Senior Vice President and General Counsel for GlaxoSmithKline (GSK), and will join the company on 2nd September 2008

Dan was formerly Chief Counsel for the US Food and Drug Administration (FDA), where he served as a primary liaison to the White House and the US Department of Health and Human Services (HHS). While leading an office of attorneys who reviewed and approved all major regulations, Dan oversaw the legislative implications of many of the most important issues facing the pharmaceutical industry today, including the reform of the Hatch-Waxman Act and subsequent legislative ratification. His office also approved and managed all agency litigation, and Dan established new procedures for the FDA legal team to follow in preparing and then litigating high-profile cases.

Dan is currently a Partner at the Washington law firm Sidley Austin LLP, where he represents pharmaceutical companies and trade associations on matters related to the FDA and government regulations.

MORE HERE

Hat Tip - Steph Gatchell

Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

By Bob Fiddaman

ISBN: 978-1-84991-120-7
CHIPMUNKA PUBLISHING

AVAILABLE FOR DOWNLOAD HERE


PAPERBACK COMING SOON
Post a Comment